These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6234254)

  • 21. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pitfalls of absent or faint kidney sign or bone scan.
    Constable AR; Cranage RW
    J Nucl Med; 1981 Jul; 22(7):658. PubMed ID: 6454765
    [No Abstract]   [Full Text] [Related]  

  • 23. [Combined bone marrow and skeletal scintigraphy in osseous and myelogenous diseases].
    Hotze A; Löw A; Mahlstedt J; Wolf F
    Rofo; 1984 Jun; 140(6):717-23. PubMed ID: 6234628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accumulation of a bone imaging agent in liver metastases from prostate carcinoma.
    Haseman MK
    Clin Nucl Med; 1983 Oct; 8(10):488-9. PubMed ID: 6228362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of quantitative and visual detection of new focal bone lesions.
    Pitt WR; Sharp PF
    J Nucl Med; 1985 Mar; 26(3):230-6. PubMed ID: 3156219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance of bone scintigraphy in the observation of the therapeutic effects in metastatic bone cancer].
    Kosuda S; Kondo M; Masaki H; Endo M; Ando Y; Takagi Y; Kubo A; Hashimoto S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 May; 42(5):454-66. PubMed ID: 6217442
    [No Abstract]   [Full Text] [Related]  

  • 27. Bone marking for biopsy using radionuclide bone imaging.
    Prasad R; Olson WH
    Cancer; 1987 Nov; 60(9):2205-7. PubMed ID: 3440231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication.
    Van Duzee BF; Schaefer JA; Ball JD; Chilton HM; Cowan RJ; Kuni C; Trow R; Watson NE
    J Nucl Med; 1984 Feb; 25(2):166-9. PubMed ID: 6233404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The assessment of response to therapy of bone metastases in breast cancer.
    Rossleigh MA; Lovegrove FT; Reynolds PM; Byrne MJ; Whitney BP
    Aust N Z J Med; 1984 Feb; 14(1):19-22. PubMed ID: 6235799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radionuclide liver and bone scanning in the evaluation of patients with endometrial carcinoma.
    Mettler FA; Christie JH; Garcia JF; Baldwin MH; Wicks JD; Bartow SA
    Radiology; 1981 Dec; 141(3):777-80. PubMed ID: 6272356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone localization.
    Robinson LA
    Surg Oncol Clin N Am; 1999 Jul; 8(3):565-76, xi. PubMed ID: 10448698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone scan and bone biopsy in the detection of skeletal metastases.
    Ron IG; Striecker A; Lerman H; Bar-Am A; Frisch B
    Oncol Rep; 1999; 6(1):185-8. PubMed ID: 9864425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the prognosis of cancer patients with metastatic bone tumors based on serial bone scintigrams.
    Ohmori K; Matsui H; Yasuda T; Kanamori M; Yudoh K; Seto H; Tsuji H
    Jpn J Clin Oncol; 1997 Aug; 27(4):263-7. PubMed ID: 9379516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between CEA, TPA, CA 15/3 and hydroxyproline, alkaline phosphatase, whole body retention of 99mTc MDP in the follow-up of bone metastases in breast cancer.
    Francini G; Montagnani M; Petrioli R; Paffetti P; Marsili S; Leone V
    Int J Biol Markers; 1990; 5(2):65-72. PubMed ID: 2283479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bone scintigraphy in the preoperative determination of the stage of breast cancer].
    Denisov LE; Iarygin LM; Ermolaeva EV; Zhuravleva LI
    Med Radiol (Mosk); 1984 Jul; 29(7):5-8. PubMed ID: 6087080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow biopsy and bone scan to detect skeletal metastases.
    Mirza I; Cuello B; Ramachandran A; Johns W
    Clin Nucl Med; 2001 Aug; 26(8):677-9. PubMed ID: 11452172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Is routine bone scanning justified during the after-care for breast cancer?].
    Schuster R; Lenzhofer R; Pirich K; Dudzak R; Gabl F
    Dtsch Med Wochenschr; 1984 Oct; 109(43):1639-42. PubMed ID: 6149114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [[Advantages and limitations of whole-body bone marrow MRI using Turbo-STIR sequences in comparison to planar bone scans] ].
    Tausig A; Manthey N; Berger F; Sommer H; Pfluger T; Hahn K
    Nuklearmedizin; 2000 Sep; 39(6):174-9. PubMed ID: 11057409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of radionuclide liver and bone scans in the evaluation of gynecologic cancers.
    Harbert JC; Rocha L; Smith FP; Delgado G
    Cancer; 1982 Mar; 49(5):1040-2. PubMed ID: 6460553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The status of nuclear medicine techniques in the diagnosis of bone metastases in breast cancer.
    Makaiová I; Kausitz J; Hupka S; Michaliková B; Vivodová M; Bohunický L
    Czech Med; 1989; 12(1):34-9. PubMed ID: 2498049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.